ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,246.95
0.18%
Dow Jones
38,814.95
0.27%
Gold vs US Dollar
2,354.635
1.11%
Brent Oil
78.435
1.72%
Bitcoin
70,984.07
0.51%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Syros Pharmaceuticals Inc (SYRS) Share Price

SYRS Syros Pharmaceuticals Inc

5.2481
-0.0119 (-0.23%)
Last Updated: 19:53:17
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Syros Pharmaceuticals Inc NASDAQ:SYRS NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -0.0119 -0.23 5.2481 5.24 5.31 5.39 5.1971 5.25 34,321 18:53:17   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 9.94M -164.57M -7.8119 -0.68 111.44M
 Type  Size  Price  Time  Units 
  193 5.2481 18:53:17 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore SYRS News
14/05/202412:30BWSyros Reports First Quarter 2024 Financial Results and Provides a Corporate Update
14/05/202411:42EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/05/202414:00BWSyros to Participate in Upcoming Investor Conferences
07/05/202412:00BWSyros to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024
09/04/202412:00BWSyros Receives Fast Track Designation from the FDA for Tamibarotene for the Treatment of Newly Diagnosed Unfit AML with RARA gene overexpression
02/04/202421:30BWSyros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
27/03/202411:30BWSyros Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update
Period
Draw mode
Data Downloads for SYRS

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Syros Pharmaceuticals Inc Articles